company

HAGEN & LYSSAND TERAPI OG VEILEDNING AS

2316 HAMAR

Return on Equity
76,77 %
Current Ratio
1,84
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue2 428 000
Net Income271 000
Total Assets763 000
Total Equity353 000
Income (NOK)2022
Revenue2 428 000
Expenditure2 080 000
Operating Profit347 000
Financial Income0
Financial Costs0
Financial Balance0
Earnings Before Tax347 000
Tax76 000
Net Income271 000
Balance (NOK)2022
Total Fixed Assets10 000
Total Current Assets753 000
Total Assets763 000
Total Retained Equity323 000
Total Equity353 000
Total Long-Term Debt0
Total Current Debt410 000
Total Equity and Debt763 000
Cash flow (NOK)2022
Sales Income2 428 000
Other Income0
Revenue2 428 000
Cost of Goods Sold0
Salary Costs1 786 000
Depreciation0
Impairment0
Expenditure2 080 000
Operating Profit347 000
Financial Income0
Financial Costs0
Financial Balance0
Dividends0
Net Income271 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets10 000
Total Fixed Assets10 000
Stock0
Total Investments0
Cash, Bank715 000
Total Current Assets753 000
Total Assets763 000
Total Equity353 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors38 000
Unpaid Taxes122 000
Dividends0
Other Current Debt173 000
Total Current Debt410 000
Total Equity and Debt763 000
Financial indicators2022
Return on Equity76,77 %
Debt-to-Equity Ratio0
Operating Profit Margin14,29 %
Current Ratio1,84
Quick Ratio1,84
Equity Ratio0,46
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English